happy to hold for another 2 years when everything is complete and share price is at $ to $3... we know phase 2a was a success on lower doses with increase strength and muscle mass whilist being safe and no adverse or serious side effects, also complimenting other treatments on market...
pretty confident phase 2a done it gives an insight on 2b, happy to speculate it being another success, but who knows might be taken over and brought out by a big pharama co.
Ann: US FDA Grants RPDD to ATL1102 for the treatment of DMD, page-93
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $177.5K | 1.730M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 136159 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 233891 | 3 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |